PhageBank™ in Treatment of Diabetic Foot Osteomyelitis
Press Release: Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company dedicated to advancing therapies that address the global rise of…
Press Release: Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company dedicated to advancing therapies that address the global rise of…
Research from Queen Mary University of London has concluded that there is convincing evidence that type 2 diabetes is associated…